BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 109919
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109919
Table 1 The results of the statistical comparison of general data between the two groups of patients, n (%)

DN group (n = 115)
T2DM group (n = 115)
t/χ2
P value
Age (years old)70.32 ± 7.4168.88 ± 8.291.4680.144
Sex1.4300.232
    Male (cases)69 (60.00)60 (52.17)
    Female (cases)46 (40.00)55 (47.83)
BMI (kg/m2)24.40 ± 2.1524.21 ± 2.430.6300.529
Smoking (cases)43 (37.39)37 (32.17)0.6900.406
Drinking (cases)39 (33.91)47 (40.87)1.1890.276
Hypertension (cases)65 (56.52)73 (63.48)1.1590.282
Hyperlipidemia (cases)79 (68.70)84 (73.04)0.5270.468
Duration of diabetes (years)12.64 ± 3.919.57 ± 2.856.8960.000
eGFR (mL/min/1.73 m2)48.52 ± 9.7778.92 ± 14.65-23.2270.000
Fasting blood glucose (mmol/L)7.59 ± 1.856.97 ± 1.882.5070.013
Fasting insulin level (mIU/L)9.53 ± 1.728.39 ± 1.195.8470.000
Blood uric acid (μmol/L)377.65 ± 65.23358.07 ± 33.294.3330.000
Urea nitrogen (mmol/L)11.84 ± 2.038.67 ± 1.6712.9990.000
Table 2 Comparison of inflammatory indicators and trimethylamine N-oxide between the two groups of patients (mean ± SD)

DN group (n = 115)
T2DM group (n = 115)
t
P value
CRP (mg/L)12.16 ± 5.446.95 ± 1.775.7600.000
IL-6 (ng/L)331.14 ± 72.13245.57 ± 42.049.7490.000
IL-8 (ng/L)345.04 ± 86.16314.12 ± 75.1310.6590.000
TNF-α (ng/L)11.28 ± 4.557.15 ± 1.802.9720.003
TMAO (ng/mL)123.47 ± 22.65108.06 ± 17.629.0410.000
Table 3 Comparison of bone metabolism indexes between the two groups (mean ± SD)

DN group (n = 115)
T2DM group (n = 115)
t
P value
PINP (μg/L)43.13 ± 6.1135.51 ± 4.8710.4610.000
β-CTX (ng/mL)0.51 ± 0.110.43 ± 0.085.9960.000
ALP (U/L)69.16 ± 7.1265.61 ± 7.093.7880.000
Lumbar spine BMD (g/cm2)0.77 ± 0.140.81 ± 0.14-2.5520.011
Hip BMD (g/cm2)0.66 ± 0.110.71 ± 0.12-3.6240.000